MoneyWorks4Me

Lyka Labs surges on resuming commercial production at Tarapur

08 Mar 2013 Evaluate

Lyka Labs is currently trading at Rs. 10.45, up by 0.69 points or 7.07% from its previous closing of Rs. 9.76 on the BSE.

The scrip opened at Rs. 10.60 and has touched a high and low of Rs. 11.64 and Rs. 10.05 respectively. So far 12,027 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 14.60 on 29-Jun-2012 and a 52 week low of Rs. 8.85 on 30-Aug-2012.

Last one week high and low of the scrip stood at Rs. 10.40 and Rs. 9.50 respectively. The current market cap of the company is Rs. 22 crore.

The promoters holding in the company stood at 23.30% while Institutions and Non-Institutions held 4.93% and 71.78% respectively.

Lyka Labs’ Tarapur factory which was closed for modernization has completed modernization and plant has been upgraded. The Company has also obtained necessary approvals and commercial production has restarted.

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..